Comprehensive Genomic Profiling of Uterine Leiomyosarcomas Identifies Frequent Clinically Relevant Genomic Alterations and Opportunities for Personalized Therapies

导出原文传递

翻译打印收藏纠错

作者： Gunderson, Camille C. ^[1] ; Santin, A. ^[2] ; delPrior, G. ^[3] ; Elvin, J. A. ^[4] ; Ramkissoon, S. ; Ali, S. M. ; McMahon, C. ; Fabrizio, D. ; Chalmers, Z. ; Frampton, G. M. ; Chmielecki, J. ; Vergilio, J. ; Suhn, J. ; Gay, L. ; Miller, V. A. ; Stephens, P. J. ; Ross, J. S. ; Moore, K. N.

作者单位： Fdn Med Inc, Cambridge, MA USA ^[1] Morehouse Sch Med, New York, NY USA ^[2] Yale New Haven Med Ctr, Dept Gynecol Oncol, 20 York St, New Haven, CT 06504 USA ^[3] Univ Oklahoma, Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA ^[4]

发布时间 2018-12-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Gynecologic Oncology

2016年143卷1期

208-209页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Comprehensive Genomic Profiling of Uterine Leiomyosarcomas Identifies Frequent Clinically Relevant Genomic Alterations and Opportunities for Personalized Therapies

Gynecologic Oncology

相似文献

Gynecologic Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comprehensive Genomic Profiling of Uterine Leiomyosarcomas Identifies Frequent Clinically Relevant Genomic Alterations and Opportunities for Personalized Therapies

Gynecologic Oncology

相似文献

Gynecologic Oncology

相关期刊

检索历史清除